Summarized by Masters of Longevity from PR Newswire.
A news release about leadership hiring at a pathology network, outlining who will guide industry partnerships and program commercialization.
Key Takeaways
- Pathology Ventures appointed a healthcare investment banker to lead partnerships and commercialization efforts for biomarker programs.
- The new executive vice president will oversee sponsor relationships, program execution, contracting, and enterprise development across member practices.
- PVL enables independent pathology practices to collaborate on standardized biomarker programs and industry projects at scale without relinquishing ownership.
